Dechra have now released their half year results for the year ending 2014. European revenues increased by a rather meagre £4M with US revenues remaining roughly flat. The cost of sales, however, also reduced, by £2.4M to give a … Continue reading
Dechra has now released their full year results for 2013. Following the decision to sell the services division, there are only two reporting segments with the vast of majority of revenues earned by the European sector, up by £64M … Continue reading
Dechra have now released their half year results for the year ending 2013. I will start with the income statement. Starting with the revenue, we see that this is up across the board and in particular, revenues in Europe … Continue reading
Dechra Pharmaceuticals is an animal pharmaceuticals company who sells products to both the companion animal and farm animal markets. These results will be dominated by the recent acquisition and I will start by looking at the income report. The total … Continue reading
Dechra have released their half year results for the first half of 2012 so without further ado I will go straight into the income report. So, if we look at the profit for the half year, it is very similar … Continue reading
Dechra House, Jamage Industrial Estate, Talke Pits, Stoke on Trent, ST7 1XW Next up for my shares blog is Dechra Pharmaceuticals. Dechra is an international pharmaceutical business focussed on the veterinary market with its key area of specialisation being the … Continue reading